• Year-over-year revenue grows 10%, operating profit up 52%, non-GAAP operating profit up 19%
• Operating cash flow of $309 million
• Announced launch of Kontor Head Strap, a premium accessory for Apple Vision Pro

ResMed Inc. announced results for its second quarter of fiscal year 2025. Revenue increased by 10% to $1.3 billion, driven by increased demand for sleep devices, masks, and residential care software. Gross margin improved 300 basis points to 58.6%, and non-GAAP gross margin improved 230 basis points to 59.2%. Income from operations increased 52%, while non-GAAP income from operations was up 19%. Net income for the quarter was $345 million, and diluted earnings per share was $2.34. Non-GAAP net income increased by 29% to $358 million, and non-GAAP diluted earnings per share increased by 29% to $2.43. Operating cash flow for the quarter was $309 million. The company also announced the launch of the Kontor Head Strap, a premium accessory for the Apple Vision Pro, and reaffirmed its commitment to expanding its Singapore operations.

ResMed did not provide any high-importance, price-sensitive forward-looking financial metrics in the announcement.